2022 ASCO Genitourinary Cancers Symposium Urothelial Cancer Updates - Episode 13

ASCO GU 2022 Updates: PARP Inhibitors in First-Line and Subsequent UC Settings

, , , ,

Experts comment on the utility of PARP inhibitors in UC and discuss data presented at ASCO GU 2022.